SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Alere Inc. And Advises Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Alere Inc. ("Alere" or the "Company") (NYSE: ALR) concerning possible violations of federal securities laws.

If you purchased or otherwise acquired Alere shares and would like more information regarding the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm's website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The investigation focuses on whether Alere and certain of its officers and/or directors violated federal securities laws. On November 4, 2016, Alere announced that the Centers for Medicare and Medicaid Services alleged that the Company's subsidiary, Arriva Medical, submitted claims for 211 deceased patients over a five-year period, and thus revoked Arriva's Medicare enrollment.

If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161104006026/en/

Copyright Business Wire 2010

If you liked this article you might like

FTC Approves Abbott's Acquisition of Alere, Stock Jumps

FTC Approves Abbott's Acquisition of Alere, Stock Jumps

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Quidel Diversifies With Alere's Triage Assets